New Publication: “Assessing SARS-CoV-2 immune markers in vaccinated asymptomatic adults after household exposure in Canada (AB-PROTECT): a prospective cohort study” in Lancet Microbe

See the publication here: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(26)00155-2/fulltext

And read about the findings here….

New Publication alert (and this one has got some immunologic hidden gems!) – "Assessing SARS-CoV-2 immune markers in vaccinated asymptomatic adults after household exposure in Canada (AB-PROTECT): a prospective cohort study" By Drs J. Breznik & C Kandel & team @lancetmicrobe.bsky.social 1/n

— Dr. Dawn Bowdish (@msmacrophage.bsky.social) 2026-09-16T12:54:00.075Z

or…

New Publication alert (and this one has got some immunologic hidden gems)!”Assessing SARS-CoV-2 immune markers in vaccinated asymptomatic adults after household exposure in Canada (AB-PROTECT): a prospective cohort study” By Drs J. Breznik (@uofguelph.bsky.social), and C Kandel (@mghtoronto.bsky.social) & team @lancetmicrobe.bsky.social 1/n

Let’s start with study design. Someone tests positive for COVID so we get blood as quick as we can from all the adults who live with them. Everyone in that household is going to be exposed so we want to figure out which immune responses protect those who don’t get sick versus those who do. 2/n

Everyone in the study has been vaccinated so they’ve all got antibodies and some T cells against the Spike protein. Some folks have some T cells that seem to be reactive against related coronaviruses or possibly a previous COVID infection. Our goal – figure out which of these protects people and which are just immunologic noise. 3/n

First stop antibodies – are people who make more antibodies or who make ‘stickier’ antibodies (i.e. ‘neutralizing’ antibodies) more protected from infection? No (although folks who didn’t wear masks or isolate their sick housemate got an antibody boost after exposure). (Neither serum IgG or IgA for the immunology aficionados) 4/n

Next stop -T cells and here’s where things get interesting. People who got sick have fewer CD8+ T cells (the ones that specialize in killing virus infected cells) against the Omicron variant, but here’s the part I’m especially excited about. T cells make cytokines which kick other immune cells into action.. 5/n

…to measure how well a T cell does it’s job, immunologists usually measure the cytokines it makes – IL2, TNF, IFNg. Other groups have seen if anti-COVID T cells making these cytokines are the secret to protection and found that they are not. So did we BUT (read on for the grand reveal)…6/n

…we looked at one less studied cytokine – GMCSF – which T cells make to kick innate immune cells like macrophages into gear during an infection. Guess what seems to be the secret to not getting COVID symptoms? Having anti-COVID T cells that make GMCSF! 7/n

Backstory – this finding has been a long-time in the making and chatting with the team we are a bit hazy on whose idea it was to check GMCSF and why we included it when the dozens upon dozens of similar studies did not. Other groups have found hints that kicking innate immunity into gear might help so we thought ‘worth a shot’ and it was! 8/n

Take home message – we may have found a new correlate of protection against COVID but we still don’t know why some people’s anti-COVID T cells make GMCSF and others don’t. As exciting as this is, there are some caveats to our study…9/n

The folks included are young(ish), healthy(ish) and this was mostly during the first Omicron wave. Whether this applies to all COVID infections and all waves remains to be seen…10/n

…as one of the 8 (8!) reviewers pointed out, we only got blood from folks after someone in their house was sick and it usually takes 2-3 days for a person to develop symptoms so their housemates may well have been in the early stages of illness before we got their blood….11/n

….because it takes about 5-10 days to make and detect a brand new GMCSF producing T cell, our interpretation was that these cells were preexisting (i.e generated from previous vaccinations or infections), but we can’t rule out that people who could fight infections were making these really quickly 12/n

….if you’ve read this far you love immunology so check out the other neat observations (people who got sick had more anti-Spike Th17 cells and T cell polyfunctionality was not associated with protection – cool, eh?). 13/n

Thanks to the whole team – it was a tremendous amount of work from the logistics of blood delivery from homes in TO to my lab in #HamOnt, to the extensive antibody responses from @gingraslab.bsky.social, Chris Verschoor’s most exceptional T cell analysis…14/n

…. the team @mcmasteruniversity.bsky.social ‘s Human Immune Testing Suite (esp Ying Wu) and of course Dr @jabreznik.bsky.social ‘s late nights doing T cell assays & Dr Kandel & McGreer’s leadership. Thanks to all involved! 15/15 https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(26)00155-2/fulltext

Why humans are uniquely sensitive to wildfire smoke – YouTube Explainer with Dr. Bowdish

Dr. Dawn Bowdish describes how the lab’s NSERC funded research uncovered a link between mutations that protect humans against tuberculosis but leave us susceptible to particulate air pollution.

Read the story here.

Based on the research below:

Bowdish DM, Sakamoto K, Lack NA, Hill PC, Sirugo G, Newport MJ, Gordon S, Hill AV, Vannberg FO. Genetic variants of MARCO are associated with susceptibility to pulmonary tuberculosis in a Gambian population. BMC Med Genet. 2013 Apr 23;14:47. doi: 10.1186/1471-2350-14-47. PMID: 23617307; PMCID: PMC3652798.

Novakowski KE, Huynh A, Han S, Dorrington MG, Yin C, Tu Z, Pelka P, Whyte P, Guarné A, Sakamoto K, Bowdish DM. A naturally occurring transcript variant of MARCO reveals the SRCR domain is critical for function. Immunol Cell Biol. 2016 Aug;94(7):646-55. doi: 10.1038/icb.2016.20. Epub 2016 Feb 18. PMID: 26888252; PMCID: PMC4980223.

Novakowski KE, Yap NVL, Yin C, Sakamoto K, Heit B, Golding GB, Bowdish DME. Human-Specific Mutations and Positively Selected Sites in MARCO Confer Functional Changes. Mol Biol Evol. 2018 Feb 1;35(2):440-450. doi: 10.1093/molbev/msx298. PMID: 29165618; PMCID: PMC5850514.

Also featured in the New York Times “Air Pollution, Evolution and The Fate of Billions of Humans” by Carl Zimmer

https://www.nytimes.com/2020/01/13/science/air-pollution-fires-genes.html

Dr Bowdish speaks on Defy Dementia™ Episode 35: A Shot at Prevention? The Shingles Vaccine & Dementia Risk

Listen to the epidsode here.

Could a routine vaccine help protect your brain? In this episode, we explore emerging research on the association between shingles vaccination and reduced dementia risk. Ron Swan shares his perspective as a community advocate focused on aging and accessibility, while Dr. Dawn Bowdish (Professor, McMaster University) breaks down what the science says, and what it doesn’t, about how vaccines may influence brain health. Together, they unpack what shingles is and what “promising but early” research about shingles vaccination could mean for reducing dementia risk.

Tune in at defydementia.org, or wherever you get your podcasts.

Web resources

Link between shingles vaccine and slowed dementia is ‘promising’ says expert – from Harvard School of Public Health




For those living with dementia, new study suggests shingles vaccine could slow the disease – from Standford Medicine




‘Strong evidence’ of lowered dementia risk: the benefits of shingles vaccination – from The Guardian





Can a routine vaccine prevent dementia? – from Harvard Health Publishing, Harvard Medical School





Is dementia a vaccine preventable condition? – from Bowdish Lab, Macrophage Biology at McMaster University





Guests:

Ron Swan
Ron Swan is a retired business development professional and entrepreneur with a strong focus on accessibility and aging-in-place. He founded Home Safe Living, a company that provided independent living and accessibility solutions across the Maritime region before selling the business to Lawton’s Drugs, a Sobeys company.





A passionate advocate for older adults, Ron continues to contribute through leadership roles, including Chair of the Board of CARP Nova Scotia and past Chair of the Seniors’ Advisory Council of Nova Scotia. He is frequently called upon to speak on aging, accessibility and community well-being.





Dr. Dawn Bowdish
Dr. Bowdish is a Professor at McMaster University and Executive Director of the Firestone Institute of Respiratory Health. Her research focuses on how aging affects the immune system, particularly how inflammation alters immune cell function and increases susceptibility to infections.Her work also examines how the aging immune system interacts with the microbiome and how these processes influence healthy and unhealthy aging. Dr. Bowdish leads the Preclinical Studies in Aging Laboratory and serves on the Board of Directors of the Lung Health Foundation, where she advocates for improved lung health and research funding for older adults.


Dr. Dawn Bowdish takes on a new leadership role with the Lung Health Foundation.

This week Dr Bowdish had the honour and privilege of becoming the next Vice-Chair of the Lung Health Foundation‘s Board of Directors. The Lung Health Foundation is Canada’s largest non-profit working to improve the lives of people living with lung conditions. Dr. Bowdish has been a Board member since 2015 where she has helped support the Lung Health Foundation’s advocacy, research, and education. She is looking forward to continuing this work and getting even more involved with this excellent organization. Lung Health starts now!

https://www.linkedin.com/feed/update/urn:li:activity:7476027081840017408/

Dr. Bowdish discusses measles elimination on TVO’s ‘The Rundown’

In 1998, Canada celebrated a huge milestone. We became one of the first countries in the world to eliminate measles. Twenty-seven years later, things are dramatically different. That’s because one year ago in New Brunswick, measles made a reappearance. What started as one case quickly spread across the country. And has continued to spread for a full year. Pay attention to that one-year mark, because it’s important. According to public health, if the chain of transmission can’t be broken in a year, it means a country can no longer call itself measles-free. Canada’s status will officially be determined at a meeting next month. We have had outbreaks since 1998, but we’ve always been able to break the chain of transmission. But not this time. Spread has been slowing. But it’s still making headlines. Like possible exposures this month in Ottawa. And Alberta recently reported its first measles death since the outbreak began. So—how did we get here? And what would it take to make measles a disease of the past. Again?

Dr. Bowdish is a panelist at the National Vaccine Summit on Adult Vaccination.

Over the past 50 years, immunizations have saved more lives in Canada than any other health intervention. With the help of a doctor, an immunologist, a pharmacist and a patient advocate, Zoomer Radio’s Liz West leads this discussion about vaccines – what’s available, where and why we need them.
National Vaccine Summit
‣ Recommended Vaccines & How To Get Them
‣ Navigating Provincial Health Systems
‣ The Role Your Pharmacist Can Play
‣ Emerging Science
‣ Fighting Disinformation & Vaccine Fatigue